Chemical Property of S-[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate
Chemical Property:
- Appearance/Colour:White crystalline powder
- Vapor Pressure:2.55E-23mmHg at 25°C
- Melting Point:165 °C
- Refractive Index:1.645
- Boiling Point:745.1 °C at 760 mmHg
- PKA:1.84±0.10(Predicted)
- Flash Point:404.4 °C
- PSA:191.05000
- Density:1.444 g/cm3
- LogP:3.84720
- Storage Temp.:2-8°C
- Solubility.:Aqueous Acid (Slightly), DMSO (Heated, Sonicated)
- XLogP3:0.5
- Hydrogen Bond Donor Count:3
- Hydrogen Bond Acceptor Count:10
- Rotatable Bond Count:10
- Exact Mass:466.10759264
- Heavy Atom Count:31
- Complexity:697
- Purity/Quality:
-
99.0% min *data from raw suppliers
Benfotiamine *data from reagent suppliers
Safty Information:
- Pictogram(s):
Xn
- Hazard Codes:Xn
- Statements:
20/21/22-36/37/38
- Safety Statements:
26-36
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C
- Isomeric SMILES:CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(\CCOP(=O)(O)O)/SC(=O)C2=CC=CC=C2)/C
- Recent ClinicalTrials:A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Recent EU Clinical Trials:Randomized double-blind, placebo-controlled parallel group study over 12 months to assess the effects of treatment with benfotiamine on morphometric, neurophysiological, and clinical measures in type 2 diabetes patients with mild to moderate symptomatic polyneuropathy - BOND Study
-
Uses
S-Benzoylthiamine O-monophosphate has been used to determine its effect on ischemia and reperfusion in skeletal muscles of rat. Vitamin B1 analog. Synthetic S-acyl derivative of Thiamine (T344185).
-
Therapeutic Function
Analgesic